SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-23-002987
Filing Date
2023-02-09
Accepted
2023-02-09 16:50:59
Documents
1
Period of Report
2023-01-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_167597942775635.html 3  
1 FORM 3 wf-form3_167597942775635.xml 3 2910
  Complete submission text file 0001628280-23-002987.txt   4565
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TOCAGEN INC. 4242 CAMPUS POINT COURT, STE. 500 SAN DIEGO CA 92121
Business Address
Kabbinavar Fairooz (Reporting) CIK: 0001774182 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35558 | Film No.: 23607022